Adipokines and the blood-brain barrier

The blood-brain barrier (BBB) is a dynamic interface that regulates molecular exchange between blood and brain. White adipose tissue secretes peptides called adipokines that influence systemic metabolism and inflammation. These molecules can affect central nervous system (CNS) function by interacting with the BBB. While some adipokines are known to cross the BBB via specific transport systems, others modulate endothelial cell behavior without direct permeation. The BBB’s role in adipokine signaling is not fully understood. Prior research has shown that leptin and tumor necrosis factor alpha (TNF-α) are transported across the BBB. However, the mechanisms for other adipokines remain unclear. This uncertainty motivates further investigation into how adipokines influence brain function. Understanding these interactions could clarify metabolic and neurological disease pathways.

This review aims to synthesize current knowledge about adipokine interactions with the BBB. Adipokines are known to influence both peripheral and central physiology, but their specific roles in BBB function remain unclear. The BBB’s selective permeability allows some molecules to enter the brain while blocking others. This study focuses on how adipokines modulate BBB integrity and CNS signaling. By examining transport mechanisms and endothelial effects, the authors seek to clarify which adipokines can influence brain function. The review also highlights differences in adipokine behavior, such as degradation rates and receptor availability. This work addresses a gap in understanding how adipokines contribute to brain health and disease. The findings may help explain links between metabolic disorders and neurological outcomes.

The authors conducted a literature review of peer-reviewed studies on adipokine interactions with the BBB. They focused on experimental models and clinical data from the past decade. Key adipokines were selected based on their prevalence in metabolic and inflammatory contexts. Leptin and TNF-α were analyzed for specific transport mechanisms across the BBB. Transforming growth factor beta-1 (TGF-β1) and adiponectin were studied for their effects on endothelial cell function. Interleukin-6 (IL-6) was examined for its potential to reach the brain but degrade rapidly. The review compared transport systems, receptor availability, and degradation rates. The synthesis of findings aimed to clarify how different adipokines influence BBB permeability and CNS signaling.

Leptin and TNF-α are transported across the BBB via specific mechanisms, allowing them to influence brain function. TGF-β1 and adiponectin do not cross the BBB but modulate endothelial cell behavior. IL-6 may reach the brain but is rapidly degraded, limiting its CNS effects. These findings suggest that adipokine interactions with the BBB vary widely. Some molecules can directly influence brain signaling, while others act indirectly by altering endothelial function. The BBB’s transport systems are selective, allowing only certain adipokines to enter the brain. This selectivity may explain how metabolic signals reach the CNS. The review highlights the importance of transporters and degradation rates in determining adipokine effects.

The BBB is a dynamic interface that selectively regulates adipokine access to the brain. Leptin and TNF-α use specific transport systems to exert CNS effects. TGF-β1 and adiponectin modulate endothelial function without crossing the BBB. IL-6 may reach the brain but is rapidly degraded. These findings suggest that adipokine signaling in the brain depends on transport and degradation mechanisms. The BBB’s role in adipokine signaling is complex and varies by molecule. The authors propose that these interactions contribute to metabolic and neurological outcomes. Further research is needed to clarify how these mechanisms influence disease processes.